Regarding the position of the President of the Society of Family and Personal Physicians, Mr. Andreas Polyneiki that they have not received relevant information on the prescription of the antiviral drug Molnupiravir, the Ministry of Health clarifies that the Personal and Specialist Doctors as well as the hospital pharmacies of the OCYPY have been informed since yesterday, Friday 14 January 2022, through a communication sent to their e-mail addresses by the Health Insurance Agency.
In the notice, the guidelines on how to prescribe the drug Molnupiravir to patients with mild/moderate disease COVID-19 through the GHS IT system were given. The Ministry of Health contacted the President of the Society of Family and Personal Physicians, Mr Andreas Polyneiki, who confirmed receipt of the communication.
It is also stressed that the pharmaceutical preparations are in the pharmacies of the state hospitals and the prescription process will start from Monday, January 17, 2022.
(AF)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO
Source
